Levocarb (Carbidopa, Levodopa)

Levodopa is a precursor that crosses the blood‑brain barrier and is converted into dopamine, the neurotransmitter deficient in Parkinson's disease. Carbidopa blocks the peripheral enzyme that would otherwise convert levodopa outside the brain, allowing more levodopa to reach the central nervous system and reducing peripheral side effects.

The appropriate dose of Levocarb is individualized by the treating physician based on disease severity, patient age, and response to therapy. Dosage adjustments are made during follow‑up visits to achieve optimal symptom control while minimizing adverse effects.

Safety data for carbidopa/levodopa during pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Levocarb product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocarb combines a dopamine precursor with a decarboxylase inhibitor, offering higher central availability of levodopa compared with levodopa alone. Compared with dopamine agonists, it may provide more consistent symptom relief but can be associated with motor complications such as dyskinesia. Choice of therapy depends on individual patient factors and physician judgment.

Levocarb tablets should be stored at room temperature, below 25 °C, in the original blister pack to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.

Levocarb is taken orally, usually with a full glass of water. It may be taken with or without food, but high‑protein meals can interfere with absorption, so spacing the dose away from protein‑rich meals is often recommended. Follow the prescribing physician’s instructions for timing and frequency.

Serious risks include dyskinesia (involuntary movements), severe orthostatic hypotension, psychiatric effects such as hallucinations or confusion, and rare allergic reactions. Patients should report sudden changes in mood, severe dizziness, or any skin swelling to their healthcare provider promptly.

Levocarb is contraindicated in patients with known hypersensitivity to carbidopa, levodopa, or any excipients. It should be avoided in individuals taking non‑selective MAO inhibitors, and caution is advised in patients with severe cardiovascular disease, uncontrolled psychiatric disorders, or significant renal impairment.